GlaxoSmithKline to publish clinical trials after US lawsuit
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7455.1513-a (Published 24 June 2004) Cite this as: BMJ 2004;328:1513
This article has a correction. Please see:
- Liza Gibson
- London
The world's second largest pharmaceutical company, GlaxoSmithKline, is to publish summaries of the results of all its clinical trials on its website once a product has been launched.
GlaxoSmithKline said it has been considering the move for several months now, but it follows on the heels of a US lawsuit, filed by Eliot Spitzer, New York state's attorney general, earlier this month.
Mr Spitzer alleged the company engaged in “repeated and persistent fraud” for concealing the results of clinical studies for its antidepressant paroxetine; these suggested the drug was ineffective and unsafe in treating depression in children and adolescents (12 June, p 1395).
Mr Spitzer also had an internal …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.